ℹ️
🇬🇧
Search
Search for people relevant for "therapy"
therapy
Person
Class
Person
Publication
Programmes
Export current view
doc. Ing. Jaroslav Chládek Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
2 classes
240 publications
Classes
class
Modern Research Methods in Pharmacology
FG50035 |
Faculty of Medicine in Hradec Králové
class
Modern research methods in pharmacology
FV50049 |
Faculty of Medicine in Hradec Králové
Publications
publication
Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers
2013 |
Faculty of Medicine in Hradec Králové
publication
Hyaluronidase: Its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs
2013 |
Faculty of Medicine in Hradec Králové
publication
Individualized pharmacotherapy of plaque psoriasis with oral methotrexate: fiction or real possibility?
2012 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study
2010 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Therapeutic monitoring of gentamicin in critically ill newborns during the first postnatal week of life
2009 |
Faculty of Medicine in Hradec Králové
publication
A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats
2008 |
Faculty of Medicine in Hradec Králové
publication
Contribution of exhaled nitric oxide measurement for asthma management in children
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis
+1
2005 |
Faculty of Medicine in Hradec Králové
publication
Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase II beta inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
2021 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
Load more publications (230)
Loading network view...